Arrhythmogenic Right Ventricular Dysplasia, Familial, 9; Arvd9
Genes related to Arrhythmogenic Right Ventricular Dysplasia, Familial, 9; Arvd9
- LMNA
- PKP2
- CEP85L
Clinical Features
Top most frequent phenotypes and symptoms related to Arrhythmogenic Right Ventricular Dysplasia, Familial, 9; Arvd9
- Congestive heart failure
- Dilatation
- Sudden cardiac death
- Syncope
- Palpitations
- Cardiac arrest
- Ventricular tachycardia
- Ventricular arrhythmia
- Abnormal EKG
- T-wave inversion
And another 7 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Arrhythmogenic Right Ventricular Dysplasia, Familial, 9; Arvd9 Is also known as arvc9, arrhythmogenic right ventricular cardiomyopathy 9.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Arrhythmogenic Right Ventricular Dysplasia, Familial, 9; Arvd9 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
CMT Advanced Evaluation - Dominant, Axonal.
By Athena Diagnostics Inc (United States).
YARS, MFN2, TRPV4, DNM2, HSPB8, GARS, HSPB1, LMNA, MPZ, NEFL, RAB7A
Specificity
10 %
Genes
34 % |
CMT Advanced Evaluation - Comprehensive.
By Athena Diagnostics Inc (United States).
YARS, PRX, GDAP1, LITAF, FIG4, MFN2, TRPV4, FGD4, SBF2, SH3TC2, DNM2, HSPB8, EGR2, GARS, GJB1, HSPB1, LMNA, MPZ, MTMR2, NDRG1 , (...)
View the complete list with 3 more genes
Specificity
5 %
Genes
34 % |
CMT Advanced Evaluation - Axonal.
By Athena Diagnostics Inc (United States).
YARS, GDAP1, MFN2, TRPV4, DNM2, HSPB8, GARS, GJB1, HSPB1, LMNA, MPZ, NEFL, RAB7A
Specificity
8 %
Genes
34 % |
CMT Advanced Evaluation - Recessive.
By Athena Diagnostics Inc (United States).
PRX, GDAP1, FIG4, FGD4, SBF2, SH3TC2, LMNA, MTMR2, NDRG1
Specificity
12 %
Genes
34 % |
LMNA (CMT2B1) DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
LMNA
Specificity
100 %
Genes
34 % |
Lamin A/C (LMNA) DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
LMNA
Specificity
100 %
Genes
34 % |
CMT Advanced Evaluation - Nonprevalent.
By Athena Diagnostics Inc (United States).
YARS, PRX, GDAP1, LITAF, FIG4, TRPV4, FGD4, SBF2, SH3TC2, DNM2, HSPB8, EGR2, GARS, GJB1, HSPB1, LMNA, MTMR2, NDRG1, NEFL, PMP22 , (...)
View the complete list with 1 more genes
Specificity
5 %
Genes
34 % |
Emery-Dreifuss Muscular Dystrophy Advanced Sequencing Evaluation.
By Athena Diagnostics Inc (United States).
SYNE2, SYNE1, TMEM43, EMD, FHL1, LMNA
Specificity
17 %
Genes
34 % |
You can get up to 513 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM MESH Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1 CANDIDIASIS, FAMILIAL, 8; CANDF8 CENTRAL CORE DISEASE OF MUSCLE; CCD 3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8 BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8